The development of arteriosclerosis is divided into five stages (Stary lesion types I-V), according to the recommendations of the American Heart Association [1] . Lesions of types I and II are regarded as normal degenerative disease. Type III is an intermediate stage, which is characterized by increasing numbers of lipid droplets that coalesce to form a lipid core, leading to the formation of a type IV lesion -an atheroma. If the plaque contains collagen, then the lesion is classified as type V (fibroatheroma) [1] . Calcification does not necessarily indicate advanced disease because it may be detected in type III lesions, first intra-cellularly and then extra-cellularly [2] . Detection of coronary calcification is therefore important, in particular because the degree of calcification has been shown to correlate with plaque load [3] [4] [5] and provides a means of verifying the presence of coronary arteriosclerosis.
Coronary imaging techniques may be direct or indirect. Indirect methods permit visualization of the coronary artery lumen but not the diseased coronary artery vessel wall. In the early stages of coronary arteriosclerosis, vessel size enlargement compensates for up to 50% stenosis from plaque formation. Indirect methods are therefore unable to visualize early signs of coronary arteriosclerosis. Direct techniques are those that permit visualization of non-calcified and calcified plaque deposits within the coronary artery vessel wall. Electron beam computed tomography (EBCT) is currently the standard technique for assessing calcified lesions. It allows direct visualization of the coronary arteries in a non-invasive manner. Coronary calcium within a plaque is accurately detected and quantified by EBCT. This modality therefore holds promise as a method for studying the natural history of coronary artery disease, irrespective of symptomatic status. Studies have shown that the presence of calcification almost invariably indicates the presence of coronary artery disease, and that the absence of calcification can almost rule out significant coronary artery disease. Moreover, a close correlation exists between the degree of calcification and severity of coronary artery disease. EBCT may also be used in young patients with risk factors in order to detect disease in pre-clinical stage, and to provide new information on the natural history of coronary artery disease.
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'gold standard' of non-invasive direct coronary imaging techniques ( Fig. 1) [6] .
Technique of electron beam computed tomography
EBCT uses an electron sweep of stationary tungsten target rings in order to generate X-ray images that can accurately detect small amounts of calcium [9] . The EBCT scanner can be operated in various scanning modes, using up to four target rings. For coronary artery imaging, the 'single-slice mode', which employs only one target ring, gives optimal spatial resolution [6] . The EBCT examination is performed using a C100, C150 or C300 scanner (GE Imatron, South San Francisco, California, U.S.A.), with contiguous, non-overlapping 3-mm slices, and an acquisition time of 100 ms. Patients are supine and, after localization of the main pulmonary artery, 36-40 slices in the craniocaudal direction through the apex of the heart are obtained, with ECG triggering at 80% of the R-R interval. The presence of coronary calcium is evaluated at each level. The threshold for calcific lesions is usually set at a CT density of 130 Hounsfield units (HU), in an area of at least 0·52 mm 2 (two pixels, 512 × 512 pixel matrix and a 26-cm field of view). This threshold has been shown to provide sufficient differentiation from surrounding tissue and blood, and has been widely accepted as signifying calcification [10, 11] . The total examination time is 3-4 min. In addition, 5-10 min are needed for evaluation, quantification of calcification and generation of a report; ideal presumption for a screening technique.
Detection of coronary calcification
EBCT permits non-invasive visualization of coronary artery calcification [10] [11] [12] [13] [14] [15] [16] [17] . In the different scan fields, all lesions exceeding 130 HU (representing coronary calcification with the image intensities similar to bone structures) are imaged (Figs 2-4) . Figure 4 is a typical example, showing calcification not only in the proximal coronary arteries but also in the distal parts of the left and right coronary arteries.
Distribution of calcification
All lesions exceeding 130 HU are regarded as calcified lesions and the distribution of calcification in the left and right coronary arteries can therefore be analyzed (Figs 3 and  4) . The distribution of calcification is semi-quantitatively described, in accordance with the 16-segment model of the American Heart Association [18] . The referring physician must be aware of the vessel segments involved, in order to correlate coronary calcification with wall motion, or location of myocardial infarction [5, 11, 19] .
Quantification of calcification
Traditionally, the scoring algorithm introduced by Agatston et al. [10] has been used to quantify coronary calcium. The calcium score is defined as the product of the area of coronary artery calcium (at least two contiguous pixels, with a CT density ≥130 HU) and a factor (rated 1-4) that is In the example shown in Fig. 2 the area is 8mm 2 and the density is 313 HU, giving a calcium grade of 3; the Agatston score is therefore 24. Calcification can be analyzed for separate coronary segments, such as those classified by the American Heart Association, and summed for each artery to yield a total score [5] . As in the example shown in Fig. 2 , calcification is typically found in segment 6 of the left anterior descending coronary artery. Figure 4 shows a lesion with an Agatston score greater than 2000.
Accuracy of electron beam computed tomography
In order to evaluate its accuracy, EBCT has been compared with intra-coronary ultrasound, which is able to visualize not only calcified but also non-calcified plaques at high resolution (100-150 µm) [5, 11] . It has been demonstrated that even single spots of calcification detected by intra-coronary
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Eur Heart J Supplements, Vol. 4 (Suppl F) September 2002 ultrasound can also be visualized using EBCT. These findings are particularly significant because the comparison was conducted in individuals with no or minimal luminal narrowing. EBCT is therefore a highly accurate method for detecting coronary calcification non-invasively. Moreover, EBCT shows a strong relationship between the number of coronary segments with plaque formation and the number of calcified coronary segments, confirming in vivo the high correlation f ound at autopsy between plaque load and amount of calcification [3, 4] . EBCT has been compared with coronary angiography in many studies [19] [20] [21] [22] [23] . Those comparisons were unable to evaluate the accuracy of EBCT because coronary angiography only visualizes the lumen of coronary arteries whereas EBCT visualizes the arterial wall. However, new developments in EBCT and particularly multislice computed tomography (MSCT) have shown that, when contrast is injected in order to discriminate the arterial wall from the coronary lumen, not only calcified but also non-calcified lesions can be visualized [24] .
Prevalence of coronary calcium
Pathological studies, conducted in soldiers and individuals who have died from causes other than cardiac disease (such as car accidents), have demonstrated the presence of advanced stages of coronary plaque formation (Stary lesions types IV/V). More than 15% of young adults have advanced coronary lesions (atheroma and fibroatheroma) [2] that can be detected by fluoroscopy [25] .
Janowitz et al. [26] demonstrated that the prevalence of calcification as visualized by EBCT is similar to that seen in pathological studies. Calcified plaques have been detected in 20% of patients aged 30-39 years, in 40% of those aged 40-49 years, in 50-60% of those aged 50-59 years, and in 70-80% of those aged 60-69 years [23] . In the Muscatine study [8] , conducted in people aged 29-37 years, coronary calcification was detected in 31% of men and 10% of women. The Coronary Artery Risk Development in Young Adults (CARDIA) study [27] , which analyzed persons aged 28-40 years, detected coronary calcification in 17% of men and 9% of women. Those studies demonstrate that coronary calcification is not only present in the advanced stages of the disease but can also be detected quite early in a high proportion of young adults in the general population.
Risk factors for coronary calcification
Risk factors for development of coronary arteriosclerosis are well known and have been classified according to cardiovascular risk in the Framingham study [28] . The following risk factors for coronary calcification were identified by multivariate regression analysis [5, 14] : age, fibrinogen, the total cholesterol/high-density lipoprotein cholesterol ratio, hypertension, male sex and positive familial history. Lowdensity lipoprotein (LDL)-cholesterol, diabetes and current smoking were positively correlated with frequency of calcified and non-calcified plaques [5] .
Topography of coronary calcification
In order to elucidate the natural history of coronary calcification, EBCT was used to investigate the distribution and prevalence of calcification in various coronary segments of young persons with or without coronary luminal narrowing [29] . Calcification was first observed in segment 6 of the left anterior descending coronary arterya finding consistent with pathological anatomy reports that coronary arteriosclerosis is first found in the proximal 2 cm of the left anterior descending coronary artery [30] . Later, calcification is also found in the middle and proximal right coronary arteries, as well as in the proximal left circumflex coronary artery. In more advanced stages, the middle part of the left anterior descending and the left main arteries are involved. Only in the most advanced stages of the disease is calcification also found in distal segments of the left anterior descending and left circumflex arteries. The distribution in the right coronary artery is more even [29] .
Coronary calcification in acute coronary syndromes
Because coronary calcification is found in the early stages of the disease, it is not surprising that it is found in a high percentage of people suffering sudden cardiac death [31] [32] [33] [34] . In a study of 50 cases of sudden death due to coronary thrombosis, plaque rupture was found in 28 out of 50 individuals and plaque erosion in 22 out of 50 individuals [31] ; 69% of the ruptured plaques and 23% of the eroded plaques were calcified. In another study, the plaques responsible for sudden cardiac death in 108 individuals (mean age 50 years) were classified as 'stable' (n = 20), 'erosion' (n = 33), 'acute rupture' (n = 37), or 'healed rupture' (n = 18), and it was found that 8 0% of ruptured plaques were calcified [34] . Similarly, in a study of 79 adults (mean age 49 ± 11 years, 71% male) who suffered sudden cardiac death, those with stable (n = 27) or ruptured (n = 30) plaques showed significantly more coronary calcification than did those with eroded plaques (n = 22) [32] . Recently, in a study of 28 individuals under 50 years old who suffered sudden cardiac death, Schmermund et al. [33] reported that calcification was present either at or close to the site of plaque rupture in a high percentage of cases. This indicates a close association between coronary calcification and plaque rupture. The presence of calcium appears to influence the mechanics of the arterial wall, increasing wall and shear stresses, and thereby increasing the likelihood of plaque rupture.
Prognostic value of coronary calcification determination
In six studies, coronary calcification (as determined using EBCT) and mortality were analyzed in order to calculate the relative risk ratio [35] [36] [37] [38] [39] [40] . In one follow-up study 288 patients who had undergone EBCT scanning at the same time as coronary angiography were contacted after a mean of 6·9 years [35] . It was found that there was a significant relative risk ratio (1·88; P < 0·05) associated with the extent of coronary calcification at baseline and the incidence of future hard cardiac events (cardiac death and non-fatal myocardial infarction). In a multicentre prospective study, 491 patients (mostly symptomatic, with suspected coronary artery disease) underwent both EBCT and coronary angiography [36] . The data showed that patients who suffered a coronary event had calcification scores of 100 or greater, whereas those who did not have an event had calcification scores below 100. In a study of over 1000 asymptomatic individuals (baseline age 53 years, 71% men), over an average followup of 3·6 years, it was found that a baseline coronary calcification score of 160 or greater was associated with an odds ratio of 15·8 for all coronary events and of 22·2 for cardiac death or non-fatal myocardial infarction [38] . In a study of 172 patients with a first acute myocardial infarction (mean age 53 ± 8 years), 165 patients (96%) showed coronary calcification by EBCT, and in 87% of the 172 patients the degree of calcification was greater than expected for their age and sex [39] .
The prognostic value of EBCT-determined coronary calcification was confirmed in a recent prospective study of 221 patients (mean age 53 ± 9 years, 54% men) [40] . Patients underwent EBCT scanning, in addition to usual care, on admission to the emergency department of a large tertiary care hospital for chest pain syndromes. When calcification was present, the relative risk ratio for coronary events was found to be 28 within an average follow-up time of 4·2 years.
Implementation of detection and grading of coronary calcification
According to the Prevention Conference V proceedings, individuals may be classified as having low, intermediate, or high risk for cardiovascular events [41] . High risk is defined as a 20% chance of suffering a cardiovascular event within 10 years. Risk factors are subdivided into causal risk factors (hypertension, hypercholesterolaemia, diabetes and smoking) and conditional risk factors (lipoprotein[a], high triglyceride levels and elevated fibrinogen). If carotid stenosis, coronary artery disease, aortic aneurysm, or peripheral vascular disease is present, then the individual is considered to be at high risk. Also at high risk are those individuals with more than two causal risk factors or more than four conditional risk factors. Individuals with two causal risk factors or three to four conditional risk factors are considered to be at intermediate risk.
The Prevention Conference V participants considered the role of several measures of subclinical disease in order to determine whether individuals at intermediate risk should be reclassified as high risk. Currently, an intima-media thickness greater than 1 mm, an ankle brachial index below 0·9, or an elevated level of C-reactive protein are the criteria used to redefine such individuals. It is anticipated that EBCT will provide an additional method of risk assessment. The advantage of EBCT is that it measures a direct sign of coronary arteriosclerosis (coronary calcification) rather than an indirect sign, such as intima-media thickness or peripheral artery disease.
Progression of coronary calcification
In order to demonstrate spontaneous progression of coronary artery disease, EBCT was used to visualize changes in calcification over time in 102 asymptomatic persons [29] . Over a mean period of 18 months, the area of calcification as well as the Agatston score were measured, because it has been suggested that the former provides the most reproducible results for serial EBCT studies [42] . Calcification was analyzed in the 12 major coronary segments, as classified by the American Heart Association. The median relative annual progression in the total area of calcification and in total Agatston score were 27% and 32%, respectively. In the near future, it is likely that, because of lower interobserver variability, the calcium volume score will be used to calculate total coronary calcium load. Thus far, all prognostic long-term studies have used the Agatston score.
Other studies have also analyzed the progression of coronary calcification over time. Maher et al. [43] measured the change in coronary calcification in 88 individuals over a 3·5-year period, and showed an average increase of 24% per year in calcification score. Möhlenkamp et al. [44] observed an increase of the Agatston score in non-obstructive coronary artery disease of 8 ± 2 and in obstructive coronary artery disease of 46 ± 9 per year [44] . Janowitz et al. [26] reported an increase of the Agatston score in unknown coronary artery disease of 20 ± 8 and in obstructive coronary artery disease of 159 ± 10. The data indicate a linear relationship between increases in Agatstons score and scores measured at the first EBCT study time. The progression mainly occurred in areas where most calcium was already detected.
Measurement of coronary calcification to study the treatment of arteriosclerosis
The detection of coronary calcification, and its quantification by EBCT, is an ideal pharmacodynamic method for studying the effects of treatment on arteriosclerosis. It has recently been shown that statins influence the development of coronary calcification [45] . A retrospective study was conducted in 149 patients (age range 32-75 years, 61% men) with no history of coronary artery disease, who were referred for EBCT screening. All patients underwent screening at baseline and at a follow-up assessment 12-15 months later. Calcium volume was calculated as an estimate of plaque burden. Statin treatment was started at the discretion of the referring physician, and serial measurements of LDL-cholesterol were correlated with change in calcium volume over time. The 44 (30%) patients who did not receive treatment had an average LDLcholesterol level of 120 mg . dl -1 or greater at follow-up, and a significant increase (52%) in calcium volume. Of the 105 (75%) patients who received statin treatment, a net reduction (-7%) in calcium volume was observed only in those patients (n = 65) whose LDL-cholesterol levels at follow-up were below 120 mg . dl -1 ; the treated patients whose LDL-cholesterol levels were 120 mg/dl or greater at follow-up (n = 40) had a significant increase (25%) in mean calcium volume, although the increase was smaller than that in the untreated group. In addition, Achenbach et al. [46] recently reported a reduction in coronary calcification progression with cerivastatin therapy. Whereas a first follow-up study showed an increase in calcium volume score of 28%, it was reduced by cerivastatin to 9%. In order to study the effect of lipid-lowering therapy on coronary calcification in more detail, several studies have been initiated. The Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) study was designed to compare aggressive lipid-lowering therapy using atorvastatin with a more moderate regimen using pravastatin, in postmenopausal women with hypercholesterolaemia [47] . In the EBCT Assessment of Coronary Calcification in High Risk Patients with Minimal or Moderate Coronary Arteriosclerosis (EBEAT), patients received intensified lipidlowering therapy with low and high doses of atorvastatin. The Treat-to-Target study uses a new phosphate-binding drug in haemodialysis patients.
Future developments
In the future, studies of coronary calcification will not only utilize EBCT but also MSCT [48] . In addition to allowing visualization of calcified plaques, MSCT is showing promise for the visualization of non-calcified plaques when contrast material is used in addition to native scanning [49, 50] . Similar results have been obtained with EBCT, allowing the concurrent visualization of coronary calcification and luminal narrowing.
Conclusion
The detection of coronary calcification in asymptomatic persons allows us to step beyond secondary prevention and to identify the high-risk patient for primary prevention. Prevention will therefore not be based on risk factor assessment alone but also on direct visualization of coronary arteriosclerosis, allowing treatment to be targeted only at those who require it, reducing cost and risk. EBCT is an ideal technique for assessment of risk and it can be used in emergency units. It may be expected that this technique will be included in future coronary heart disease guidelines, in order to classify patients at intermediate risk more accurately. EBCT is already in use as a new tool in pharmacodynamic studies of arteriosclerosis.
